Furazolidone, tetracycline and omeprazole: A low-cost alternative for Helicobacter pylori eradication in children

Jornal de Pediatria

Volumn 84, Issue 2, 2008, Pages 160-165

  Machado, Rodrigo Strehl ^a,c   Da Silva, Marcello Ruiz ^b   Viriato, Aírton ^a  

^a Children's Hospital Candido Fontoura   (Brazil)

^b Hospital Guilherme Alvaro   (Brazil)

^c NONE   (Brazil)

Author keywords

Child; Clinical trial; Furazolidone; Helicobacter pylori treatment; Tetracycline

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; DOXYCYCLINE; FURAZOLIDONE; OMEPRAZOLE; TETRACYCLINE; UREASE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; ATROPHY; CHILD CARE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DIZZINESS; DRUG COST; DYSPEPSIA; EPIGASTRIC PAIN; ERADICATION THERAPY; FATIGUE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NAUSEA; PATHOGENESIS; PATIENT COMPLIANCE; PEPTIC ULCER; SCHOOL CHILD; SIDE EFFECT; STOMACH BIOPSY; STOMACH DISEASE; TASTE DISCRIMINATION; TASTE DISORDER; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FURAZOLIDONE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; OMEPRAZOLE; PROSPECTIVE STUDIES; TETRACYCLINE; TREATMENT OUTCOME;

EID: 43049118637     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1772     Document Type: Article

References (27)

1. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-81.
2. Bittencourt PF, Rocha GA, Penna FJ, Queiroz DM. Gastroduodenal peptic ulcer and Helicobacter pylori infection in children and adolescents. J Pediatr (Rio J). 2006;82:325-34.
3. Drumm B, Koletzko S, Oderda G. Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori. J Pediatr Gastroenterol Nutr. 2000;30:207-13.
4. Crone J, Granditsch G, Huber WD, Binder C, Innerhofer A, Amann G, et al. Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000. J Pediatr Gastroenterol Nutr. 2003;36:368-71.
5. Kawakami E, Ogata SK, Portorreal AC, Magni AM, Pardo ML, Patricio FR. Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents. Arq Gastroenterol. 2001;38:203-6.
6. Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol. 2003;3:20.
7. Kawakami E, Machado RS, Ogata SK, Langner M, Fukushima E, Carelli AP, et al. Furazolidone-based triple therapy for H pylori gastritis in children. World J Gastroenterol. 2006;12:5544-9.
8. Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut. 1999; 45 Suppl 2:II60-8.
9. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-81.
10. Ogata SK, Kawakami E, Patricio FR, Pedroso MZ, Santos AM. Evaluation of invasive and non-invasive methods for the diagnosis of Helicobacter pylori infection in symptomatic children and adolescents. Sao Paulo Med J. 2001;119:67-71.
11. Dani R, Queiroz DM, Dias MG, Franco JM, Magalhaes LC, Mendes GS, et al. Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. Aliment Pharmacol Ther. 1999;13:1647-52.
12. Khurana R, Fischbach L, Chiba N, Van Zanten SV, Sherman PM, George BA, et al. Meta-analysis: Helicobacter pylori eradication treatment efficacy in children. Aliment Pharmacol Ther. 2007;25:523-36.
13. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter. 1999;4:135-9.
14. Agwuh KN, MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother. 2006;58:256-65.
15. Perri F, Festa V, Merla A, Quitadamo M, Clemente R, Andriulli A. Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection. Helicobacter. 2002;7:99-104.
16. Neu HC, Gootz TD. Antimicrobial Chemotherapy. In: Baron S, editor. Medical Microbiology. 4th ed. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid= mmed.chapter.662. Access:16/09/2007.
17. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808-25.
18. Frota LC, da Cunha Mdo P, Luz CR, de Araujo-Filho AH, Frota LA, Braga LL. Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. Arq Gastroenterol. 2005;42:111-5.
19. Silva FM, Eisig JN, Chehter EZ, Silva JJ, Laudanna AA. Omeprazole, furazolidone and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer. Rev Hosp Clin Fac Med. 2002;57:205-8.
20. Graham DY, Opekun AR, Belson G, El-Zimaity HM, Carlson MR. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Aliment Pharmacol Ther. 2005;21:165-8.
21. Lu H, Zhang DZ, Hu PJ, Li ZS, Lu XH, Fang XC, et al. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study. Aliment Pharmacol Ther. 2001;15:1975-9.
22. Chi CH, Lin CY, Sheu BS, Yang HB, Huang AH, Wu JJ. Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment Pharmacol Ther. 2003;18:347-53.
23. Dore MP, Marras L, Maragkoudakis E, Nieddu S, Manca A, Graham DY, et al. Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen. Helicobacter. 2003;8:307-9.
24. Boyanova L, Nikolov R, Lazarova E, Gergova G, Katsarov N, Kamburov V, et al. Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years. J Med Microbiol. 2006;55: 65-8.
25. Vallejos MC, Garrido OL, Cáceres LD, Madrid AM, Defilippi C, Defilippi CC, et al. Prevalencia de la resistencia a metrodinazol, claritromicina y tetraciclina en Helicobacter pylori aislado de pacientes de la Region Metropolitana. Rev Med Chil. 2007;135:287-93.
26. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006;354:832-40.
27. Matsushima M, Suzuki T, Kurumada T, Watanabe S, Watanabe K, Kobayashi K, et al. Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection. J Gastroenterol Hepatol. 2006;21:232-6.